You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a ...

Vertex and AbbVie both beat the bear market last year. Both these top companies have reached an important moment in their ...

After 2022, there is heightened interest from political officials to regulate the industry. The report claims that ...

Nano Dimension is once again trying to buy Stratasys. Stratasys rejected the last offer and is actively preventing a hostile ...

FDIC and SIPC insurance will protect your bank deposits and brokerage securities if a firm collapses. Find out how they work ...

Many or all of the products here are from our partners that compensate us. It’s how we make money. But our editorial ...

Enbridge is growing its renewable energy investments. With a dividend yield of more than 7%, the stock is attractive for ...

Micron Technology battles a stubborn semiconductor market downturn with strict inventory management and limited chip ...

Disney World has spent the last 18 months celebrating the resort turning 50. Its biggest rival has been quiet during Disney ...

Share prices have nearly nothing to do with a company’s total market value or business prospects. 8x8 is both low-priced and ...

Arcturus beat expectations with its Q4 results. The company also provided an encouraging update on its pipeline programs.

Medical Properties Trust is selling 11 Australian hospitals for $1.2 billion. The deal should help the healthcare REIT ...